- By ICR Secretariat
- Posted Tuesday, October 1, 2019
NHS will not pay for 'life-changing' migraine drug
A migraine drug that has been described as "life changing" by some patients will not be made available on the NHS outside of Scotland.
Erenumab - also known by the name Aimovig - is one of the first bespoke migraine drugs in decades and has been described by doctors as a "huge deal".